Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01228175 · ClinicalTrials.gov registry record · Phase 4
Effectiveness of Varenicline: Testing Individual Differences
A Phase 4 study, sponsored by The Mind Research Network.
- Completed
- Registry status
- Phase 4
- Development phase
- 218
- Enrollment target
NCT01228175 is a Phase 4 study that has completed, run by The Mind Research Network. The registered enrollment target is 218 participants.
The verdict
NCT01228175, a Phase 4 study, has completed, sponsored by The Mind Research Network.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 218 participants
- Enrollment target
Study Summary
The study will evaluate the effectiveness of smoking cessation using Varenicline versus placebo. Effectiveness will be measured by the average number of cigarettes smoked per smoking day for up to 36 weeks.
Interventions
- DRUG Placebo
- DRUG Varenicline
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 218 participants |
| Start Date | 2010-03 |
| Est. Completion | 2016-03 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01228175
The ClinicalTrials.gov registry entry for NCT01228175 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 218 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is The Mind Research Network, which has 17 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Placebo is the first listed.
NCT01228175 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01228175 about?
NCT01228175 is a clinical study titled "Effectiveness of Varenicline: Testing Individual Differences". The study will evaluate the effectiveness of smoking cessation using Varenicline versus placebo. Effectiveness will be measured by the average number of cigarettes smoked per smoking day for up to 36 weeks.
What is the current status of trial NCT01228175?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 218 participants. The study started on 2010-03. Estimated completion is 2016-03.
What interventions are being tested in trial NCT01228175?
The interventions under investigation include: Placebo (DRUG), Varenicline (DRUG).
Who is sponsoring clinical trial NCT01228175?
This trial is sponsored by The Mind Research Network, which has 17 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.